Hofseth Biocare (Norway) Analysis
| HBC Stock | NOK 1.31 0.01 0.76% |
Hofseth Biocare ASA is overvalued with Real Value of 1.25 and Hype Value of 1.31. The main objective of Hofseth Biocare stock analysis is to determine its intrinsic value, which is an estimate of what Hofseth Biocare ASA is worth, separate from its market price. There are two main types of Hofseth Biocare's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Hofseth Biocare's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Hofseth Biocare's stock to identify patterns and trends that may indicate its future price movements.
The Hofseth Biocare stock is traded in Norway on Oslo Stock Exchange, with the market opening at 09:00:00 and closing at 16:20:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Norway.
Hofseth |
Hofseth Stock Analysis Notes
About 53.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.38. Hofseth Biocare ASA had not issued any dividends in recent years. The entity had 866:863 split on the 16th of October 2020. Hofseth BioCare ASA, a biotech company, offers value added biomarine ingredients and finished products for human consumption and pet in Norway. The company was founded in 2000 and is headquartered in lesund, Norway. HOFSETH BIOCARE operates under Pharmaceuticals And Biosciences classification in Norway and is traded on Oslo Stock Exchange. It employs 44 people. To learn more about Hofseth Biocare ASA call the company at 47 73 10 22 00 or check out https://www.hofsethbiocare.no.Hofseth Biocare ASA Investment Alerts
| Hofseth Biocare ASA generated a negative expected return over the last 90 days | |
| Hofseth Biocare ASA may become a speculative penny stock | |
| Hofseth Biocare ASA has high historical volatility and very poor performance | |
| Hofseth Biocare ASA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 87.62 M. Net Loss for the year was (126.46 M) with profit before overhead, payroll, taxes, and interest of 28.51 M. | |
| Hofseth Biocare ASA has accumulated about 36.52 M in cash with (61.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 53.0% of the company shares are held by company insiders |
Hofseth Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hofseth Biocare's market, we take the total number of its shares issued and multiply it by Hofseth Biocare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Hofseth Profitablity
Hofseth Biocare's profitability indicators refer to fundamental financial ratios that showcase Hofseth Biocare's ability to generate income relative to its revenue or operating costs. If, let's say, Hofseth Biocare is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Hofseth Biocare's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Hofseth Biocare's profitability requires more research than a typical breakdown of Hofseth Biocare's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.14) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.07. Technical Drivers
As of the 29th of November, Hofseth Biocare retains the Risk Adjusted Performance of (0.11), standard deviation of 4.03, and Market Risk Adjusted Performance of 1.05. Hofseth Biocare technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Hofseth Biocare ASA standard deviation, maximum drawdown, kurtosis, as well as the relationship between the information ratio and potential upside to decide if Hofseth Biocare is priced fairly, providing market reflects its last-minute price of 1.31 per share.Hofseth Biocare ASA Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Hofseth Biocare middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Hofseth Biocare ASA. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Hofseth Biocare Outstanding Bonds
Hofseth Biocare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hofseth Biocare ASA uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hofseth bonds can be classified according to their maturity, which is the date when Hofseth Biocare ASA has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Hofseth Biocare Predictive Daily Indicators
Hofseth Biocare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Hofseth Biocare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Hofseth Biocare Forecast Models
Hofseth Biocare's time-series forecasting models are one of many Hofseth Biocare's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Hofseth Biocare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Hofseth Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Hofseth Biocare prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hofseth shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Hofseth Biocare. By using and applying Hofseth Stock analysis, traders can create a robust methodology for identifying Hofseth entry and exit points for their positions.
Hofseth BioCare ASA, a biotech company, offers value added biomarine ingredients and finished products for human consumption and pet in Norway. The company was founded in 2000 and is headquartered in lesund, Norway. HOFSETH BIOCARE operates under Pharmaceuticals And Biosciences classification in Norway and is traded on Oslo Stock Exchange. It employs 44 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Hofseth Biocare to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Other Information on Investing in Hofseth Stock
Hofseth Biocare financial ratios help investors to determine whether Hofseth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hofseth with respect to the benefits of owning Hofseth Biocare security.